AbbVie
Facts
25 propertiesIdentity
- Instance of
- business, biopharmaceutical company, public company[5][6]
- Official website
- www.abbvie.com[26]
- Short name
- ABBV[32]
- Legal form
- Delaware corporation[30][31]
- Official name
- AbbVie Inc.[29]
Location
- Headquarters location
- North Chicago[9]
- Country
- United States[3][4]
- Located in the administrative territorial entity
- North Chicago[2]as of 2026-10-21
where from?
- Record
- ror.org/02g5p4n58
- Edition
- 20261021 · as of 2026-10-21
- Bronze
7a7bf58d5ac18436v2.15-2026-10-20-ror-data.zip- Transform
- 4ort-mint · ror:20261021 · version not recorded
Industry and activity
- Product or material produced
- medication, therapy[27][28]
Financials
- Operating income
- 18.1B (3.4B–18.1B, n=12)
People
- Chief executive officer
- Richard A. Gonzalez (2013–2024), Robert A. Michael (2024–present)[10]
- Board member
- Richard A. Gonzalez (2013–present), Robert Alpern (2013–present), Roxanne Austin (2013–present), Willie Burnside (2013–present), Tom Freyman (2020–present), Brett Hart (2016–present), Melody Meyer (2017–present), Becky Roberts (2018–present), Glenn Tilton (2013–present), Rick Waddell (2012–present), Robert A. Michael (2024–present), Jennifer L. Davis (2023–present), Susan Quaggin (2023–present), Edward J. Rapp (2013–present)[54][55][56][57][58][59]
Relations
- Owned by
- The Vanguard Group (2024), BlackRock (2024)[7][8]
- Child organization or unit
- AbbVie Deutschland GmbH & Co. KG, AbbVie (Bermuda), AbbVie (Bahamas), AbbVie GK, AbbVie (Australia), AbbVie s.r.o.[11][12][13][14][15][16]
- Separated from
- Abbott Laboratories (2013–present)[25]
More facts +3
- Number of viewers/listeners
- 681,461 (2025)
- Social media followers
- 78k (68k–78k, n=3)
- Stock exchange
- New York Stock Exchange (2013–present)[19]
- ROR ID
- 02g5p4n58
- ISNI
- 0000000405724227
- Legal Entity Identifier
- FR5LCKFTG8054YNNRU85
- VIAF cluster ID
- 1457155191921682440005
- GND ID
- 1179216946
- OpenAlex ID
- F4320309117as of 2026-10-11
where from?
- Source
- OpenAlex
- Edition
- 20261011 · as of 2026-10-11
- Licence
- CC0 1.0 Universal
- Bronze
- not in the catalog
- Transform
- 4ort-mint · openalex:20261011 · version not recorded
- GRID ID
- grid.431072.3
- Central Index Key
- 0001551152
- Crunchbase organization ID
- abbvie
- EU Transparency Register ID
- 934069612666-51
- Facebook username
- AbbVieGlobal
- Freebase ID
- /m/0rzs09c
Show all 35 identifiers +23
- Genius artist ID
- Abbvie-formerly-a-division-of-abbott-pharmaceuticals
- Golden ID (archived)
- AbbVie_Inc.-5EAJB8
- Google Scholar organization ID
- 12853406975335582193
- Great Russian Encyclopedia portal ID
- abbvie-e4d6bf
- HAND ID
- 65C7-1238-9461-6682-AFD9
- ISIN
- US00287Y1091
- ISO 9362 SWIFT/BIC code
- ABBVUS44XXX
- Instagram username
- abbvie
- LinkedIn company or organization ID
- abbvie
- New York Post topic ID
- abbvie
- Open Funder Registry funder ID
- 100006483
- OpenCorporates organization ID
- us_de/5126809
- OpenStreetMap way ID
- 595840648
- PermID
- 5037613143
- Press information URL
- news.abbvie.com/presskits.cfm, news.abbvie.com
- Ringgold ID
- 359181
- SCImago Institutions Rankings ID
- 85917
- Scilit organization ID
- 22899
- Topic's main category
- Category:AbbVie
- Wikirate Company ID
- 47751
- X (Twitter) username
- abbvie (2012–present)
- YouTube channel ID
- UC023GwYXeUQQ6TYHlCaxjOA (2016–present)
- YouTube handle
- abbviefrance5402 (2025)
← Ultimate parent organization 65
← Parent organization 61
← Affiliated with 7
Industry 2
Instance of 2
Legal form 2
Owned by 2
Product or material produced 2
Country 1
Headquarters location 1
Location of formation 1
Owned entities 1
Preceded by (successor) 1
Separated from 1
Stock exchange 1
Topic's main category 1
← Category's main topic 1
0 sources
Financials
0001551152-26-000008high ≥ 0.90 · emerging ≥ 0.65 · low below — calibrated against hand-rated truth (single-source .44 · two-source .62 · production-typical .70), so a band is a measurement, not a promise. High is rare by design: it needs both a supported assertion and an evidence sentence. A confirmed or contradicted chip is a Wikidata cross-check; no chip means Wikidata has no value for that property — the ordinary case here, and it says nothing either way. A confirm-only note marks a property whose check can never disagree (Wikidata's border and capital data is not exhaustive), so silence there is a limit of the check, not of the claim.
evidence “The company entered into a definitive agreement in June 2026 to be acquired by AbbVie (ABBV) for a total equity value of approximately $10.9 billion.” finanznachrichten.de · read source
evidence “AbbVie is a giant among pharmaceutical stocks, focusing on immunology, oncology, and neuroscience therapies.” fool.com · read source
evidence “Not all of those may work out as hoped, but it’s impressive pipeline makes AbbVie the pick over Johnson & Johnson.” fool.com · read source
Show 9 low-confidence claims
Published, not hidden — scoring low is not a reason to withhold a sourced claim. A contradicted chip means Wikidata holds a different value; both are shown so you can judge.
evidence “AbbVie Expands Oxford R&D in £120m UK Investment” zenopa.com · read source
evidence “What AbbVie's Skyrizi EMA filing means for ABBV stock” finance.yahoo.com · read source
evidence ““The data that’s missing from the PDB is exactly the data that’s present in our internal data,” John Karanicolas, head of computational drug discovery at the pharma company AbbVie in Chicago, Illinois, told Nature last year.” nature.com · read source
evidence “That included arranging a US$10bn delayed draw term loan in July for US healthcare firm AbbVie to fund its US$10.9bn acquisition of Apogee Therapeutics.” zawya.com · read source
evidence “AbbVie is a focused biopharmaceutical player known for its dominance in immunology, whereas Johnson & Johnson operates a broader business model following its separation from its consumer health division.” finance.yahoo.com · read source
evidence “AbbVie is a giant among pharmaceutical stocks, focusing on immunology, oncology, and neuroscience therapies.” fool.com · read source
evidence “Several other authors reported serving as consultants, receiving research grants or honoraria, or having advisory roles with Sanofi and other pharmaceutical companies, including AbbVie, Amgen, and Bristol-Myers Squibb.” medscape.com · read source
evidence “It also demonstrates that AbbVie’s investments in oncology are producing clinically meaningful pipeline assets rather than relying exclusively on acquisitions.” insidermonkey.com · read source
evidence “Deciding whether to buy AbbVie Inc (NYSE:ABBV) or Eli Lilly and Co (NYSE:LLY) requires weighing different growth engines.” finance.yahoo.com · read source